Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial

Abroad (travel likely)RecruitingPHASE3

Conditions

Non-melanoma Skin Cancer · Carcinoma, Squamous Cell · Carcinoma, Basal Cell · Keratinocyte Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Calgary, Calgary, Alberta, Canada
Contact: Study coordinator (Coralea Bignell) · coralea.bignell@albertahealthservices.ca
Contact: Principal Investigator (Ngam Lam)
University of Alberta, Edmonton, Alberta, Canada
Contact: Study coordinator (Kelly Kim) · kkim6@ualberta.ca
Contact: Principal Investigator (Sita Gourishankar)
Jaggi Rao (Sub-investigator)
Vancouver General Hospital, Vancouver, British Columbia, Canada
Contact: Study coordinator (Natalie Ng) · natalie.ng@ubc.ca
Contact: Principal Investigator (Sunil Kalia)
St. Paul's Hospital, Vancouver, British Columbia, Canada
Contact: Study coordinator (Anushka Sood) · asood1@providencehealth.bc.ca
Contact: Principal Investigator (John Gill)
Sheila Au (Sub-investigator)
The Ottawa Hospital, Ottawa, Ontario, Canada
Contact: Study coordinator (Christine Lennox) · clennox@ohri.ca
Contact: Principal Investigator (Jennifer Beecker)
Toronto General Hospital, Toronto, Ontario, Canada
Contact: Study coordinator (Marsida Stafa) · SPRINTR@wchospital.ca
Contact: Principal Investigator (An-Wen Chan)
Women's College Hospital, Toronto, Ontario, Canada
Contact: Study coordinator (Stephanie Jewell) · SPRINTR@wchospital.ca
Contact: Principal Investigator (An-Wen Chan)

Study leads

An-Wen Chan
Principal Investigator
Women's College Hospital
Sang Joseph Kim
Principal Investigator
University Health Network, Toronto

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Cancer, Metastatic · Cancer · Cancer of Pancreas

Abroad (travel likely)Recruiting

Birmingham, United States · Mobile, United States

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

Haematological Malignancy · Melanoma · Thyroid Cancer, Papillary

Abroad (travel likely)RecruitingPHASE2, PHASE3

Belfast, United Kingdom · Birmingham, United Kingdom

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Breast Cancer, NOS · CNS Primary Tumor, NOS · Cervical Cancer, NOS

Abroad (travel likely)Recruiting

Fairbanks, United States · Kingman, United States

The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population

Actinic Keratoses · Aging · Non-Melanoma Skin Cancer

Abroad (travel likely)Recruiting

Fairborn, United States